Aplastic Anemia Stem Cell Therapy – HemaXellerate – IND #15376 <<<------------- ;-) HemaXellerate is a personalized cellular therapeutic product designed to stimulate blood production in patients whose bone marrow is not properly functioning. Fat stem cell based product to treat bone marrow that has been damaged Bone marrow damage occurs from radiation, chemo, or chronic conditions HemaXellerate uses patient’s own fat as source of endothelial cells to heal damaged bone marrow Tox studies have been completed and are awaiting analysis. Aims to provide “natural” replacement to synthetic cytokines Synthetic cytokines that stimulate bone marrow are $18 billion market